Assembly Biosciences, Inc. (ASMB)
Last updated: 2026-10-20 23:26:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Assembly Biosciences, Inc. (ASMB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.16, with a market capitalization of $409.04M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.94 to $39.71. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$409.04M | |
$20.23 | |
$808.32 | |
$7.69 | |
$20.16 | |
181.33K | |
286.43K | |
-- | |
$39.71 | |
$19.94 | |
-- | |
-- |
Assembly Biosciences, Inc. (ASMB) After-Hours Stock Price
Assembly Biosciences, Inc. (ASMB) is trading at $21.18 in after-hours trading as of 2026-10-20 23:06:00, up 5.06% ($1.02) from the regular-session close of $20.16.
After-hours trading shows how investors are pricing ASMB after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Assembly Biosciences, Inc. (ASMB) 7-Day Stock Price Change
Over the past seven days, Assembly Biosciences, Inc. (ASMB) moved from $23.53 to $21.16, representing a decline of 10.09% ($2.38).
The stock traded between $19.94 and $23.83 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 213.78 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ASMB 52-Week Price Position
Position in Range: 6.1%
ASMB is currently trading at $21.16, placing it 6.1% of the way from its 52-week low of $19.94 to its 52-week high of $39.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Assembly Biosciences, Inc. (ASMB)?
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Assembly Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 73 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Assembly Biosciences, Inc. (ASMB) Stock on MEXC
Eligible investors can buy real shares of Assembly Biosciences, Inc. (ASMB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Assembly Biosciences, Inc. (ASMB) stock price today?
2.Is ASMB stock going up or down today?
3.What is ASMB pre-market price?
4.What is ASMB after-hours price?
5.Is ASMB stock trading now?
6.Where does ASMB sit relative to its 52-week high and low?
7.What sector is Assembly Biosciences, Inc. in?
8.What is Assembly Biosciences, Inc.'s market capitalization and where is it listed?
9.How is ASMB valued in terms of P/E ratio and EPS?
10.Does Assembly Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ASMB Stock Calculator
Estimate the value between ASMB shares and USD.
ASMB Shares to USD
1.00 ASMB shares = 21.155 USD
Calculations are estimates based on the latest available price and are for reference only.


